SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022611
Filing Date
2022-11-07
Accepted
2022-11-07 16:14:35
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20220930.htm   iXBRL 10-Q 3412680
2 EX-31.1 eftr-ex31_1.htm EX-31.1 21492
3 EX-31.2 eftr-ex31_2.htm EX-31.2 21451
4 EX-32.1 eftr-ex32_1.htm EX-32.1 12112
5 EX-32.2 eftr-ex32_2.htm EX-32.2 12077
  Complete submission text file 0000950170-22-022611.txt   13046086

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20220930_cal.xml EX-101.CAL 46378
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20220930.xsd EX-101.SCH 89159
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20220930_def.xml EX-101.DEF 366087
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20220930_pre.xml EX-101.PRE 503740
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20220930_lab.xml EX-101.LAB 640740
77 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20220930_htm.xml XML 2736459
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 221365614
SIC: 2834 Pharmaceutical Preparations